Adenosine A
G-protein-coupled receptors
cortical neurons
cross-antagonism
heteromer print
purinergic P1 receptors
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
17 Jul 2020
17 Jul 2020
Historique:
received:
25
06
2020
revised:
10
07
2020
accepted:
13
07
2020
entrez:
26
7
2020
pubmed:
28
7
2020
medline:
17
2
2021
Statut:
epublish
Résumé
The aim of this paper was to check the possible interaction of two of the four purinergic P1 receptors, the A
Identifiants
pubmed: 32709103
pii: ijms21145070
doi: 10.3390/ijms21145070
pmc: PMC7404137
pii:
doi:
Substances chimiques
Receptor, Adenosine A2A
0
Receptor, Adenosine A3
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministerio de Economía, Industria y Competitividad, Gobierno de España
ID : RTI2018-094204
Organisme : Ministerio de Economía, Industria y Competitividad, Gobierno de España
ID : SAF2017-84117-R
Références
Nat Chem Biol. 2009 Mar;5(3):131-4
pubmed: 19219011
Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):654-9
pubmed: 17194762
Oncotarget. 2018 Feb 6;9(17):13593-13611
pubmed: 29568380
Front Neurosci. 2018 Feb 06;12:43
pubmed: 29467608
Scientifica (Cairo). 2014;2014:362937
pubmed: 24864225
Glia. 1999 Apr;26(2):119-28
pubmed: 10384877
J Neurosci. 2006 Feb 15;26(7):2080-7
pubmed: 16481441
Nature. 2000 Oct 12;407(6805):747-50
pubmed: 11048721
Naunyn Schmiedebergs Arch Pharmacol. 2013 Nov;386(11):963-72
pubmed: 23812646
Br J Pharmacol. 2014 Mar;171(5):1102-13
pubmed: 24024783
Nature. 1999 Jun 17;399(6737):697-700
pubmed: 10385123
Front Pharmacol. 2016 Mar 31;7:76
pubmed: 27065866
Handb Exp Pharmacol. 2017;238:339-357
pubmed: 26721676
J Pharmacol Exp Ther. 2016 Sep;358(3):580-7
pubmed: 27358483
Biochem Pharmacol. 2015 Jul 15;96(2):131-42
pubmed: 25986885
Cell Metab. 2020 Jul 7;32(1):56-70.e7
pubmed: 32589947
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5135-9
pubmed: 15044695
Acta Physiol (Oxf). 2015 Aug;214(4):467-80
pubmed: 25683861
Methods Mol Biol. 2013;963:147-69
pubmed: 23296610
J Neurosci. 2000 Nov 15;20(22):RC110
pubmed: 11069979
BMC Biol. 2016 Apr 05;14:26
pubmed: 27048449
Mol Neurobiol. 2017 Aug;54(6):4537-4550
pubmed: 27370794
J Biol Chem. 2010 Aug 27;285(35):27346-59
pubmed: 20562103
Purinergic Signal. 2013 Sep;9(3):433-49
pubmed: 23657626
Methods. 2002 Aug;27(4):358-65
pubmed: 12217652
Mol Neurobiol. 2018 Jun;55(6):4718-4730
pubmed: 28717967
J Pharmacol Toxicol Methods. 2001 Sep-Oct;46(2):61-71
pubmed: 12481843
Pflugers Arch. 2015 Feb;467(2):429-42
pubmed: 24841338
Mov Disord. 2013 Jul;28(8):1138-41
pubmed: 23483627
J Biol Chem. 2004 Aug 20;279(34):35671-8
pubmed: 15159403
Int Rev Neurobiol. 2014;119:71-86
pubmed: 25175961
J Biol Chem. 2010 Nov 5;285(45):35092-103
pubmed: 20807772
Clin Neuropharmacol. 2015 Mar-Apr;38(2):41-6
pubmed: 25768849
J Biol Chem. 1996 Jun 21;271(25):15272-8
pubmed: 8663009
Annu Rev Physiol. 1992;54:211-25
pubmed: 1373278
BMC Biol. 2018 Feb 28;16(1):24
pubmed: 29486745
Parkinsonism Relat Disord. 2009 Jul;15(6):406-13
pubmed: 19446490
Biochem Pharmacol. 2020 Feb;172:113718
pubmed: 31751537
Prog Brain Res. 2014;211:183-200
pubmed: 24968781